US Stock MarketDetailed Quotes

X4 Pharmaceuticals (XFOR)

Watchlist

3.940
-0.060-1.50%

Close May 15 16:00 ET

4.010
+0.070+1.78%

Post 17:05 ET

371.62MMarket Cap-1.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

X4 Pharmaceuticals (XFOR) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

-90.60%2.71M

1,273.21%35.11M

79.08%2.57M

215.18%1.77M

250.44%1.97M

28.81M

2.56M

1.43M

560K

563K

Operating revenue

-90.60%2.71M

1,273.21%35.11M

79.08%2.57M

215.18%1.77M

250.44%1.97M

--28.81M

--2.56M

--1.43M

--560K

--563K

Cost of revenue

-87.32%598K

622.33%5.76M

20.53%364K

54.63%351K

21.64%326K

4.72M

797K

302K

227K

268K

Gross profit

-91.24%2.11M

1,567.95%29.36M

94.70%2.2M

324.62%1.41M

458.31%1.65M

24.09M

1.76M

1.13M

333K

295K

Operating expense

-33.15%22.42M

-18.81%116.24M

-29.70%25.9M

-16.97%28.92M

-18.46%27.88M

-10.07%33.53M

33.15%143.16M

46.22%36.85M

28.00%34.83M

32.50%34.19M

Selling and administrative expenses

-53.62%6.97M

-29.26%43.52M

-51.26%7.38M

-26.02%11.59M

-28.25%9.53M

-13.85%15.02M

73.27%61.52M

52.56%15.15M

92.55%15.66M

30.13%13.28M

Research and development costs

-16.55%15.45M

-10.93%72.72M

-14.66%18.52M

-9.58%17.34M

-12.25%18.35M

-6.75%18.51M

13.37%81.64M

42.10%21.7M

0.48%19.17M

34.06%20.91M

Operating profit

-115.04%-20.31M

38.56%-86.88M

33.64%-23.7M

20.26%-27.51M

22.61%-26.23M

74.68%-9.44M

-31.51%-141.4M

-41.73%-35.72M

-26.77%-34.5M

-31.36%-33.9M

Net non-operating interest income expense

97.53%-29K

-43.38%-4.3M

80.62%-201K

-149.72%-1.36M

-156.46%-1.57M

-45.54%-1.18M

-150.96%-3M

-135.15%-1.04M

-120.73%-543K

-161.11%-611K

Non-operating interest income

105.37%2.11M

-20.68%4.58M

56.67%1.99M

-51.84%901K

-57.51%665K

-3.85%1.03M

25.91%5.77M

-12.32%1.27M

34.80%1.87M

71.23%1.57M

Non-operating interest expense

-3.04%2.13M

1.23%8.88M

-5.12%2.19M

-6.50%2.26M

2.57%2.23M

17.45%2.2M

51.77%8.77M

22.16%2.3M

47.74%2.41M

89.55%2.18M

Other net income (expense)

-99.14%94K

-88.79%12.03M

99.11%-25K

40.17%-980K

-98.33%2.1M

180.11%10.94M

1,306.14%107.26M

-142.96%-2.81M

-106.50%-1.64M

522.68%125.36M

Gain on sale of security

-99.26%80K

562.76%12.78M

99.33%-18K

63.73%-676K

-86.93%2.64M

178.74%10.83M

-72.75%1.93M

-142.14%-2.67M

-107.41%-1.86M

167.70%20.22M

Special income (charges)

----

--0

----

--105M

--0

--105M

-Gain on sale of property,plant,equipment

----

--0

----

--105M

--0

--105M

Other non- operating income (expenses)

-86.67%14K

-326.81%-753K

95.10%-7K

-234.51%-304K

-479.86%-547K

0.00%105K

-40.07%332K

-167.45%-143K

1,229.41%226K

-28.71%144K

Income before tax

-6,505.38%-20.24M

-113.13%-79.16M

39.53%-23.93M

18.64%-29.85M

-128.29%-25.7M

100.61%316K

63.26%-37.14M

-107.17%-39.56M

-1,509.52%-36.68M

263.12%90.85M

Income tax

-86.77%41K

-300.00%-30K

105.56%37K

78.95%34K

297.44%310K

681.82%258K

-42.31%15K

20.00%18K

Net income

-7,277.66%-20.24M

-111.48%-79.2M

39.92%-23.93M

18.75%-29.82M

-128.34%-25.74M

100.54%282K

62.98%-37.45M

-108.16%-39.82M

-1,492.02%-36.7M

263.04%90.83M

Net income continuous Operations

-7,277.66%-20.24M

-111.48%-79.2M

39.92%-23.93M

18.75%-29.82M

-128.34%-25.74M

100.54%282K

62.98%-37.45M

-108.16%-39.82M

-1,492.02%-36.7M

263.04%90.83M

Minority interest income

Net income attributable to the parent company

-7,277.66%-20.24M

-111.48%-79.2M

39.92%-23.93M

18.75%-29.82M

-128.34%-25.74M

100.54%282K

62.98%-37.45M

-108.16%-39.82M

-1,492.02%-36.7M

263.04%90.83M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-7,277.66%-20.24M

-111.48%-79.2M

39.92%-23.93M

18.75%-29.82M

-128.34%-25.74M

100.54%282K

62.98%-37.45M

-108.16%-39.82M

-1,492.02%-36.7M

263.04%90.83M

Basic earnings per share

-500.00%-0.16

66.55%-1.87

95.61%-0.2632

87.41%-0.69

-125.53%-3.47

100.51%0.04

67.25%-5.59

-124.72%-6

-1,726.67%-5.48

237.27%13.59

Diluted earnings per share

-500.00%-0.16

66.55%-1.87

95.61%-0.2632

87.41%-0.69

-125.57%-3.47

100.51%0.04

67.25%-5.59

-124.72%-6

-1,726.67%-5.48

237.07%13.57

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	-90.60%2.71M	1,273.21%35.11M	79.08%2.57M	215.18%1.77M	250.44%1.97M	28.81M	2.56M	1.43M	560K	563K
Operating revenue	-90.60%2.71M	1,273.21%35.11M	79.08%2.57M	215.18%1.77M	250.44%1.97M	--28.81M	--2.56M	--1.43M	--560K	--563K
Cost of revenue	-87.32%598K	622.33%5.76M	20.53%364K	54.63%351K	21.64%326K	4.72M	797K	302K	227K	268K
Gross profit	-91.24%2.11M	1,567.95%29.36M	94.70%2.2M	324.62%1.41M	458.31%1.65M	24.09M	1.76M	1.13M	333K	295K
Operating expense	-33.15%22.42M	-18.81%116.24M	-29.70%25.9M	-16.97%28.92M	-18.46%27.88M	-10.07%33.53M	33.15%143.16M	46.22%36.85M	28.00%34.83M	32.50%34.19M
Selling and administrative expenses	-53.62%6.97M	-29.26%43.52M	-51.26%7.38M	-26.02%11.59M	-28.25%9.53M	-13.85%15.02M	73.27%61.52M	52.56%15.15M	92.55%15.66M	30.13%13.28M
Research and development costs	-16.55%15.45M	-10.93%72.72M	-14.66%18.52M	-9.58%17.34M	-12.25%18.35M	-6.75%18.51M	13.37%81.64M	42.10%21.7M	0.48%19.17M	34.06%20.91M
Operating profit	-115.04%-20.31M	38.56%-86.88M	33.64%-23.7M	20.26%-27.51M	22.61%-26.23M	74.68%-9.44M	-31.51%-141.4M	-41.73%-35.72M	-26.77%-34.5M	-31.36%-33.9M
Net non-operating interest income expense	97.53%-29K	-43.38%-4.3M	80.62%-201K	-149.72%-1.36M	-156.46%-1.57M	-45.54%-1.18M	-150.96%-3M	-135.15%-1.04M	-120.73%-543K	-161.11%-611K
Non-operating interest income	105.37%2.11M	-20.68%4.58M	56.67%1.99M	-51.84%901K	-57.51%665K	-3.85%1.03M	25.91%5.77M	-12.32%1.27M	34.80%1.87M	71.23%1.57M
Non-operating interest expense	-3.04%2.13M	1.23%8.88M	-5.12%2.19M	-6.50%2.26M	2.57%2.23M	17.45%2.2M	51.77%8.77M	22.16%2.3M	47.74%2.41M	89.55%2.18M
Other net income (expense)	-99.14%94K	-88.79%12.03M	99.11%-25K	40.17%-980K	-98.33%2.1M	180.11%10.94M	1,306.14%107.26M	-142.96%-2.81M	-106.50%-1.64M	522.68%125.36M
Gain on sale of security	-99.26%80K	562.76%12.78M	99.33%-18K	63.73%-676K	-86.93%2.64M	178.74%10.83M	-72.75%1.93M	-142.14%-2.67M	-107.41%-1.86M	167.70%20.22M
Special income (charges)	----	--0	--0	--0	--0	----	--105M	--0	--0	--105M
-Gain on sale of property,plant,equipment	----	--0	--0	--0	--0	----	--105M	--0	--0	--105M
Other non- operating income (expenses)	-86.67%14K	-326.81%-753K	95.10%-7K	-234.51%-304K	-479.86%-547K	0.00%105K	-40.07%332K	-167.45%-143K	1,229.41%226K	-28.71%144K
Income before tax	-6,505.38%-20.24M	-113.13%-79.16M	39.53%-23.93M	18.64%-29.85M	-128.29%-25.7M	100.61%316K	63.26%-37.14M	-107.17%-39.56M	-1,509.52%-36.68M	263.12%90.85M
Income tax	0	-86.77%41K	0	-300.00%-30K	105.56%37K	78.95%34K	297.44%310K	681.82%258K	-42.31%15K	20.00%18K
Net income	-7,277.66%-20.24M	-111.48%-79.2M	39.92%-23.93M	18.75%-29.82M	-128.34%-25.74M	100.54%282K	62.98%-37.45M	-108.16%-39.82M	-1,492.02%-36.7M	263.04%90.83M
Net income continuous Operations	-7,277.66%-20.24M	-111.48%-79.2M	39.92%-23.93M	18.75%-29.82M	-128.34%-25.74M	100.54%282K	62.98%-37.45M	-108.16%-39.82M	-1,492.02%-36.7M	263.04%90.83M
Minority interest income
Net income attributable to the parent company	-7,277.66%-20.24M	-111.48%-79.2M	39.92%-23.93M	18.75%-29.82M	-128.34%-25.74M	100.54%282K	62.98%-37.45M	-108.16%-39.82M	-1,492.02%-36.7M	263.04%90.83M
Preferred stock dividends
Other preferred stock dividends							0
Net income attributable to common stockholders	-7,277.66%-20.24M	-111.48%-79.2M	39.92%-23.93M	18.75%-29.82M	-128.34%-25.74M	100.54%282K	62.98%-37.45M	-108.16%-39.82M	-1,492.02%-36.7M	263.04%90.83M
Basic earnings per share	-500.00%-0.16	66.55%-1.87	95.61%-0.2632	87.41%-0.69	-125.53%-3.47	100.51%0.04	67.25%-5.59	-124.72%-6	-1,726.67%-5.48	237.27%13.59
Diluted earnings per share	-500.00%-0.16	66.55%-1.87	95.61%-0.2632	87.41%-0.69	-125.57%-3.47	100.51%0.04	67.25%-5.59	-124.72%-6	-1,726.67%-5.48	237.07%13.57
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm